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The genus Mycobacterium includes several pathogens that cause severe disease in humans, like Mycobacterium tuberculosis (M. tb), the infectious agent causing tuberculosis. Genetic tools to engineer mycobacterial genomes, in a targeted or random fashion, have provided opportunities to investigate M. tb infection and pathogenesis. Furthermore, they have allowed the identification and validation of potential targets for the diagnosis, prevention, and treatment of tuberculosis. This review describes the various methods that are available for the generation of mutants in Mycobacterium species, focusing specifically on tools for altering slowgrowing mycobacteria from the M. tb complex. Among others, it incorporates the recent new molecular biological technologies (e.g. ORBIT) to rapidly and/or genome-wide comprehensively obtain targeted mutants in mycobacteria. As such, this review can be used as a guide to select the appropriate genetic tools to generate mycobacterial mutants of interest, which can be used as tools to aid understanding of M. tb infection or to help developing TB intervention strategies.
The genus Mycobacterium includes several pathogens that cause severe disease in humans. Tuberculosis (TB), caused by Mycobacterium tuberculosis (M. tb), is the world's leading infectious killer, before HIV and malaria, killing around 1.6 million people each year [1] . Furthermore, the emergence of drug-resistant strains constitutes a serious health threat and requires innovative initiatives to stop the TB epidemic.
Genetic analysis of mycobacteria is essential to initiate the understanding of M. tb infection. Furthermore, it can aid developing TB intervention strategies, for example by validating drug targets or engineering improved live-attenuated vaccines. Many bacterial genes and pathways that are vital for the intracellular growth and survival of M. tb are known and several of such bacterial virulence mechanisms have been suggested as attractive drug targets [2, 3] . Also in the field of vaccine research, switching off important immunomodulatory or virulence genes has shown great promise to develop strains with an increased protective effect against M. tb [4-7]. Nevertheless, the largest part of the~4000 genes in the mycobacterial genome remains unexplored. The functional validation of the bacterial components presumed to be involved in M. tb-host interactions, and the validation of candidate genes in M. tb or Mycobacterium bovis Bacillus Calmette Gu erin (BCG) for improved vaccine development requires the generation of mutants.
Genetic engineering in mycobacteria is challenging due the impenetrable nature of the mycobacterial cell wall, the slow growth of the bacteria, and the pathogenicity of some species. Furthermore, the high frequency of illegitimate recombination [8] and the availability of few antibiotic selection markers [9, 10] complicates the generation of genetically engineered strains.
Over the past decades, a variety of genetic engineering approaches has been developed and the mycobacterial genetic toolbox has expanded dramatically. This review aims to provide a guide for the generation of mutants in Mycobacterium species. It focuses specifically on tools for altering slow-growing mycobacteria from the M. tb complex.
Targeted mutagenesis
One-step and two-step allelic exchange using vectors
The first systems that enabled mutagenesis of slowgrowing mycobacteria were based on one-step allelic exchange (AE) (Fig. 1A) [11, 12] . Therefore, mycobacteria are electroporated with suicide vectors (or linear dsDNA) containing flanking sequences of a locus of interest and an antibiotic resistance gene, whereafter a double cross-over between the homologous regions on the genome and the allelic exchange substrate (AES) leads to the formation of a marked mutant. Later on, direct repeats of recombination sites (e.g. FRT, loxP, res, or dif sites) were incorporated to allow subsequent site-specific recombination-mediated marker gene removal (Table 1) [13] [14] [15] [16] [17] [18] [19] . Important improvements were made by applying a two-step AE procedure to create unmarked mutants ( Fig. 1B) [20] [21] [22] . Different AES were designed containing a.o. multiple resistance markers (KanR, HygR), the lacZ gene and the negative selection marker SacB. In a first step, a single cross-over between a genomic locus of interest and its region of homology on the suicide vector integrates the entire construct into the mycobacterial genome. These single cross-over transformants are specifically selected for by a combination of one or multiple resistance markers and optionally the visual LacZ screening tool, which turns the cells blue when grown in the presence of X-Gal.
Since the marker genes are outside the region of homology, double cross-over transformants or antibiotic-resistant false positives would remain white. In a second step, the genome is forced to undergo a second cross-over event to delete the negative selection marker SacB by plating on medium containing sucrose. This second cross-over can either occur between the regions involved during the first cross-over, regenerating the WT locus, or between up or downstream regions of homology, generating an unmarked knockout (KO) mutant. Since SacB shows a high rate of spontaneous inactivation [23,24], a second screening mechanism (blue/white screening or antibiotic sensitivity) is advised. Barkan et al. [25] showed that the Escherichia coli galactokinase gene (galK) can be used as a counterselectable marker in mycobacteria, allowing the introduction of both counterselection genes (sacB and galK) on the delivery vectors for a tight counterselection (up to 100%). Recently, Arnold et al.
[26] implemented this dual counterselection in their optimized suicide vectors (the pKO series), that are part of a uniform cloning platform (based on fragment exchange using the type IIS restriction enzyme SapI) to facilitate mycobacterial genetics (also includes vectors for gene complementation, conditional knockdowns and protein production).
These methods (or variations thereof) are still used today to create AE mutants in both fast-and slowgrowing species, as they are easy to implement. Although successful in many (but certainly not all) cases, the above described methods remain cumbersome and take on average 4-12 months to create a single KO mutant. This is mainly due to the low efficiency of electroporation to introduce foreign DNA into the mycobacterial cells and the low rate of homologous recombination (HR). Transformation efficiencies are typically in the range of 10 3 to 10 5 transformants per microgram of DNA for slow-growing Mycobacterium species such as M. bovis BCG and M. tb [9]. Since typical recombination frequencies are in the range of 10 À4 to 10 À6 for single cross-overs and at least an order of magnitude lower for double cross-over events, it is clear that we are on the limit for reliably obtaining AE mutants using this approach. Improvements were made to overcome these limitations for example, by optimizing electroporation protocols [9,27,28] and by using UV-irradiated or alkali-treated donor DNA to stimulate HR [20, 29] . In 2017, a novel approach has been published to transform mycobacteria, namely shockwave-assisted bacterial transformation [30] , that uses a number of consecutive shockwaves to introduce DNA in mycobacteria. However, the maximum amount of colony-forming units that could be attained was 10 5 Fig. 1 . One-step (A) or two-step (B) allelic exchange (AE) strategies using vector systems and specialized transduction (C). (A) One-step AE involves a double cross-over between homology regions in the genome and the allelic exchange substrate (AES) on the delivery vector, leading to the formation of a marked mutant, that can be unmarked by site-specific recombination. (B) In two-step AE, the first cross-over will integrate the delivery vector in the genome. By applying negative selection, a second cross-over is forced, that will restore the WT locus or generate an unmarked mutant. (C) Specialized transduction. First, the AES plasmid carrying homology regions to the gene of interest (RH and LH) needs to be generated. Type II RE Van91I, recognizing a palindromic repeat that is interrupted by 5 bp of unspecified sequence (CCANNNN^NTGG), can be used to construct the AES plasmid by means of a directional 4-fragment ligation step. This AES plasmid and the shuttle phasmid (e.g. phAE159) are digested with PacI and ligated to form concatemers, which are packaged in vitro in k particles (using the k cos site) for the transduction of Escherichia coli to isolate shuttle phasmids containing the gene-specific AES plasmid. These are then electroporated to Mycobacterium smegmatis to generate the specialized transducing phage at permissive temperature (30°C). The generated phages can then be used to infect a Mycobacterium strain of interest at restrictive temperature (37°C) to create gene deletion mutants via double homologous recombination.
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In summary, the introduction of DNA in mycobacteria is one of the limiting factors to reliably obtain AE mutants. This has been solved by the use of phages; the exploration of the mycobacteriophage diversity provided a method to efficiently introduce foreign DNA in mycobacteria.
Specialized transduction
Mycobacteriophages are viral particles that are able to naturally infect one or more Mycobacterium species and have naturally evolved to very efficiently introduce their phage DNA into the mycobacterial cell. With appropriate adjustment of the multiplicity of infection, almost every cell in the culture is transduced (~100% transformation efficiency) [31-33]. Jacobs et al. [34] pioneered their use as efficient gene transfer systems in mycobacteria and coined the name 'shuttle phasmid'. An E. coli-Mycobacterium shuttle phasmid consists of a conventional E. coli replicating plasmid inserted into a nonessential region of the mycobacteriophage DNA, allowing for the transfer of DNA across both genera. Bardarov et al. [31] developed several temperature-sensitive phasmid variants that are able to replicate and form plaques at permissive temperature (30°C), but are unable to do so at restrictive temperature (37°C).
The transformation efficiencies that can be reached using mycobacteriophage delivery far exceed those using electroporation. Therefore, transduction as a method to introduce recombinant DNA into the mycobacterial cell is perfectly suited to replace or knock out genes by HR. This approach was first described by Bardarov et al. [35] and has been termed specialized transduction. The complete method consists out of several steps (Fig. 1C) . First, the plasmid expressing the AES needs to be constructed. The AES contains the regions of homology to the gene of interest and a hygromycin resistance marker flanked by resolvase recognition sites. The AES plasmid also contains a PacI restriction site, a k cos site, and an origin of replication for E. coli (OriE). Secondly, the plasmid moiety of the temperature-sensitive shuttle phasmid is replaced by the gene-specific AES plasmid. Therefore, both vectors (shuttle phasmid and AES plasmid) are digested with PacI and ligated together with the formation of concatemers (long DNA molecules containing different copies of the two vectors). These concatemers are in vitro packaged in phage k particles via the k cos site on the AES plasmid and transduced into E. coli. The circular cosmid DNA from hygromycin-resistant transformants can then be isolated and electroporated to Mycobacterium smegmatis. The cells are incubated at the permissive temperature (30°C) to allow phage replication, so that infectious phage particles can be isolated. These phage particles can then be used to transduce any Mycobacterium strain of interest at the restrictive temperature (37°C), inhibiting phage replication. Instead, the cells can undergo a double cross-over to replace the endogenous gene with a hygromycin-disrupted mutant allele (like for the one-step AE strategy). After validation of the mutation in the hygromycin-resistant transformants, the selection marker(s) can be removed by transiently expressing the resolvase gene (tnpR).
Numerous genes have been knocked out using this method in many Mycobacterium species, including M. bovis BCG substrains [36] [37] [38] , virulent M. tb [39, 40] , and M. avium [41, 42] . In 2014, an update of this method was published [43] , to improve upon several rate-limiting steps of specialized transduction. First, the authors shortened the multistep process of engineering AES for HR to a one-step cloning procedure by means of a type IIP restriction enzyme, Van91I (or DraIII, BstAPI, or AlwNI) ( Fig. 1C) . Therefore, the homology regions are both flanked by Van91I sites. The vector can then be constructed by means of a directional 4-fragment ligation (two Van91I digested vector fragments and two Van91I-digested PCR amplicons containing the homology regions). If the sequence within the PCR amplicon contains a Van91I recognition site, the restriction enzyme BstAPI, AlwNI, or DraIII is used instead. Secondly, they reported on an improved shuttle phasmid (phAE159) with an increased cloning capacity (~10 kb for PhAE159 vs~4.5 kb for PhAE87), allowing the incorporation of more versatile genetic constructs. Due to this increased cloning capacity, the negative selection marker SacB could be incorporated in the AES, simplifying the subsequent removal of the res-flanked cassette by counterselection on sucrose medium. Lastly, they generated a conditionally replicating resolvase-expressing phage (PhAE280) to rapidly remove the res-(sacB-hygR)-res cassette from the genome, obviating the curing step of the resolvaseexpressing plasmids. Using the improved method, the authors have already generated over 100 confirmed deletion mutants in M. tb H37Rv in diverse functional gene classes.
Double-and single stranded recombineering
Although specialized transduction increases the efficiency of mycobacterial transformation significantly compared to traditional electroporation, the phage construction step remains laborious and has to be repeated for every gene KO. Furthermore, double cross-overs by the endogenous HR machinery are still rare events and in slow-growing strains such as M. bovis BCG and M. tb, illegitimate recombination occurs at a considerable incidence [8], further confounding AE experiments. The efficiency of recombination-based genetic engineering, also known as recombineering, can be promoted 10-to 100-fold by use of phage-encoded recombineering systems. First used in yeast [44] , the method in its most popular form was first implemented in E. coli [45, 46] . In 2007, van Kessel and Hatfull implemented the gp60 and gp61 proteins of mycobacteriophage Che9c to stimulate recombineering in mycobacteria [47] . The authors optimized an inducible (acetamidase promoter-based) expression system for the gp60 and/or gp61. Cells expressing gp60 and gp61 were induced with acetamide and transformed with linear dsDNA containing an AES. In M. tb, they observed an increase in HR that was at least an order of magnitude higher compared to control strains not expressing the recombineering proteins. An update of the system used a temperature-sensitive recombineering plasmid containing a SacB counterselection marker for straightforward curing of the plasmid afterward, a visual screening tool (GFP) to allow easy discrimination of the recombined transformants and site-specific recombination sites to allow subsequent removal of introduced resistance markers [17].
Next to dsDNA recombineering, introduction of ssDNA oligo's in cells expressing the ssDNA-binding protein gp61 was shown to allow the precise introduction of point mutations into the mycobacterial genome [48] . Although the authors mainly focused on directly selectable target genes, they also showed the system's potential for gene mutations without a selectable phenotype [48] . Herefore, the ssDNA oligo was electroporated in excess together with a vector carrying a co-selectable marker. The basic idea is to eliminate all nontransformed cells and enrich for the transformed ones that are likely to have incorporated the mutated oligo into the genome as well. In M. smegmatis, 5-10% of resistant transformants also had the desired mutation, while this was an order of magnitude lower in M. tb (0.5-1%).
However, now more than 10 years later, few laboratories appear to have picked up ssDNA recombineering as a genetic engineering tool. It is likely that its use to introduce nonselectable mutations in slow-growing mycobacterial species is cumbersome, since the recombineering efficiency in these types of mycobacteria is 5-to 10-fold reduced compared to M. smegmatis and further depends on the sequence context of the oligo and target locus within a species [48] . Altogether, this necessitates the screening of 100-1000 single clones to identify a single clone with the mutation of interest, without an a priori knowledge that the mutation is present. This laborious screening appears to be a major bottleneck in the ssDNA recombineering approach.
Enhanced specialized transduction using recombineering
Tufariello et al. [49] further optimized mycobacterial genetic engineering by combining the excellent transformation efficiencies of transducing phages with an increased recombination by the Che9C recombineering proteins, leading to a 10-to 100-fold increase in the number of transformants. Deletion of mycobacterial RecD (involved in the repair of double stranded breaks (DSB) [50] ) further increased the AE efficiency in M. tb several fold, both in the presence and absence of the recombineering system [49] . Altogether, specialized transduction in a recombineering and DrecD background improved gene replacement efficiencies 100-to 150-fold compared to the WT M. tb strain [49] . While recombineering is generally applicable in any Mycobacterium species, the DrecD phenotype requires the generation of a recD disruption strain in advance. Nevertheless, these substantial improvements gave rise to a consortium of laboratories, seeking to create a genome-wide set of KO phages to disrupt all nonessential mycobacterial genes in various M. tb backgrounds [43, 49, 51] or any other close relative such as M. bovis BCG. Once the rate-limiting step of phage construction is completed, the semi-high throughput engineering of any slow-growing Mycobacterium species appears within reach.
ORBIT, oligonucleotide-mediated recombineering followed by Bxb1 integrase targeting
The Hatfull lab did vast amounts of work to characterize different phage systems, including the Che9 RecET recombineering system [48, 52] and the Bxb1 phage integration system [53] [54] [55] [56] [57] [58] [59] [60] . Their huge efforts enabled the Sassetti lab to develop a new system for targeted mutagenesis of mycobacteria, namely ORBIT (Oligonucleotide-mediated Recombineering followed by Bxb1 Integrase Targeting), which was recently published [61] . The system combines two efficient phage recombination systems to create a versatile method for chromosomal engineering of mycobacteria, with the possibility of generating both deletions and insertions or fusions using essentially the same method.
Two phage proteins are involved in the ORBIT system ( Fig. 2A-D) . First, the Che9c RecT annealase incorporates a synthetic targeting oligonucleotide (ssDNA) (attP site flanked by 45-70 bp homology arms) into the chromosome via HR, resulting in the introduction of an attP site at a precise location in the chromosome. Subsequently, the Bxb1 integrase integrates a 'payload plasmid' in the genome via attP-attB site-specific recombination, creating an attL and attR site flanking the integrated payload plasmid. The payload plasmid contains a selectable marker to select for the correctly engineered strains. The targeting oligonucleotide and payload plasmid are co-transformed into a RecT and Int-expressing strain allowing the selection of drug-resistant homologous recombinants in a single step [61] .
Depending on the nature of the targeting oligonucleotide and payload plasmid, one can create KOs, insertions (e.g. fusion of C-terminal tags) or replacements (e.g. promoter replacement). For KOs, the oligonucleotide is designed to replace the target gene by the attP site ( Fig. 2C ). For C-terminal tags, the oligonucleotide is designed to insert the attP site before the stop codon of the gene, after which a payload plasmid is used to introduce the tag (Fig. 2D ). Murphy et al. generated a set of payload plasmids to create C-terminal targeted fusions, facilitating fluorescence analysis and affinity purifications. To construct promoter replacement, the oligonucleotide is designed to replace the endogenous promoter with the attP site and the payload plasmid will subsequently introduce the alternative promoter. Using ORBIT, the authors were able to construct insertions and deletions in over 100 genes in M. smegmatis and M. tb. They documented that typically 20-200 clones are obtained per transformation (~6 mL starting culture electroporated with 1 lg targeting oligonucleotide and 200 ng payload), whereafter only 2-4 candidates need to be analyzed by PCR to identify at least one correct clone [61] .
The advantages of this method for generating deletion mutants are obvious. Instead of generating dsDNA substrates (or specialized transduction phages) for the generation of a mutant via AE, you just need to design one chemically synthesized oligonucleotide, which makes the method well suited for the construction of libraries of mutants. Moreover, the generated mutation is selectable, in contrast a mutation obtained by ssDNA recombineering. Furthermore, the system not only allows the creation of gene deletions, but also supports the generation of C-terminal fusions, promoter replacements, and so on. Additionally, each generated mutant can be tagged by including a unique DNA barcode sequence in the targeting oligonucleotide. The diversity of modifications that can be made with different payload plasmids offers new possibilities for functional screening of mutant libraries generated with ORBIT [61] .
A disadvantage of this method, compared to specialized transduction, is that an electroporation step is needed to introduce the targeting oligonucleotides and payload plasmid, limiting the overall efficiency of the method. Additional drawbacks of the system are the remaining vector, producing the recombination functions, and the remaining selection marker in the mutants. The negative selection marker SacB was already added to the vector, generating pKM461, to permit straightforward curing of this plasmid ( Fig. 2A ) [61] . Moreover, the remaining selection marker can be removed by introducing the Bxb1 integrase and gp47 protein (recombination directionality factor) [57] , that will promote site-specific recombination between the created attL and attR sites, restoring the attP site and thereby removing the selection marker ( Fig. 2E ). This process was already shown to work for M. smegmatis gene deletion mutants [61] , not yet for slow-growing mycobacteria. If needed, one could introduce the negative selection marker GalK on the payload plasmid to make the removal of the selection marker more straightforward. However, iterative construction of strains containing multiple mutations using ORBIT could be challenging due to the remaining attP site in the genome. For this it would be recommended to first introduce all the desired different mutations and then, in a final step, all mutations could be unmarked at the same time. Especially here, the introduction of a counterselectable marker on the payload would be advisable.
Gene editing with CRISPR-CAS?
CRISPR or Clustered Regularly Interspaced Short Palindromic Repeat sequences are a distinct class of repetitive DNA sequences across the prokaryotic domain, that are commonly associated with CRISPRassociated (Cas) proteins [62, 63] . These CRISPR-Cas systems provide some primitive form of cell immunity against phage infections, by degrading invading DNA sequences [64] . The CRISPR-Cas9 system of Streptococcus pyogenes has been successfully implemented for genome editing [65] in numerous organisms across the eukaryotic kingdom, ranging from yeast [66] to human cell lines [67] [68] [69] and complete higher eukaryotic model organisms [70] [71] [72] [73] . In eukaryotic cells, DSBs introduced by Cas9 can efficiently be repaired by NHEJ (nonhomologous end joining) to create indel mutations (or by homology-directed repair using repair templates) [74] . However, most bacterial species lack NHEJ capacity, therefore the reports on the use of CRISPR-Cas for targeted genome editing in bacterial organisms came later on [75] [76] [77] [78] .
In the field of CRISPR-Cas, it became generally known that the use of the CRISPR-Cas9 system to create mutants in bacteria (including mycobacteria [79] ) is restricted due to the toxicity of SpCas9 (S. pyogenes Cas9). In CRISPR interference (CRISPRi), a catalytically dead Cas9 (dCas9) is used and no DSBs are generated, which allows the use of CRISPR-dCas9 systems to achieve gene silencing in mycobacteria [80] [81] [82] . Luckily, the natural diversity of Cas effector proteins opened opportunities for the field.
The first successful application of CRISPR-Cas gene editing in M. smegmatis used a mycobacterium codonoptimized FnCpf1 (Francissella novicida CRISPR-associated endonuclease in Prevotella and Francisella 1) in combination with oligonucleotide recombineering (CRISPR-Cas12a-assisted recombineering) to create markerless and scarless mutations [83] . Mycobacteria are first transformed with FnCpf1 (tetracyclin-inducible promoter) and the Che9c gp60 and gp61 recombineering proteins. Thereafter, a temperature-sensitive plasmid expressing a crispr RNA (crRNA) targeting the gene of interest and disruption oligonucleotides (ssDNA or markerless dsDNA) are transformed into the cells. The formed crRNA-Cas12a complexes will bind and cut the gene of interest. The created DSB is repaired by recombineering, resulting in point mutations, deletions or insertions, depending on the administered oligonucleotides. The efficiency of introducing a site-directed mutation by CRISPR-Cas12a-assisted recombineering ranged from 60% to 80% (using ssDNA oligonucleotides) [83] , while the insertion/deletion efficiency depended on the length of these insertions and deletions (~30-60% efficiency for 1 kb deletions using markerless dsDNA) [83] . In M. smegmatis, CRISPR-Cas12a-assisted recombineering thus gives a clear advantage over markerless recombineering without Cpf1 (only 5-10% efficiency) [47] .
Sun et al. [79] thereafter published the successful application of the CRISPR-FnCpf1-assisted NHEJ system in M. smegmatis, without the addition of recombineering proteins or a homologous DNA template. For gene editing, cells are simply transformed with one plasmid coexpressing FnCpf1 (hsp60 promoter) and a crRNA targeting a specific gene. In this system, the generated DSBs are repaired by NHEJ (adding additional nucleotides or resulting in deletions) [79] , in contrast to the CRISPR-Cas12a-assisted recombineering system of Yan et al. [83] , where no NHEJ was detected. The CRISPR-FnCpf1-assisted NHEJ system in including the Che9c phage RecT annealase and the Bxb1 phage integrase (Int), both driven from the Ptet promoter. It additionally contains the negative selection marker SacB for straightforward curing of the plasmid after the mutant has been created. This replicating plasmid needs to be transformed to the strain to prepare it for ORBIT (B) Targeting oligonucleotide and nonreplicating payload plasmid. The targeting oligonucleotide (ssDNA) consists of the Bxb1 attP site (48 bases) flanked by 45-70 bases of homology at each side to the target gene (LH and RH), while the payload plasmid provides the Bxb1 attB site. To generate gene fusions, the attB site is flanked by the fusion gene/tag designed to be in frame with the target gene. (C, D) ORBIT-promoted gene deletion (C) or EGFP-fusion to the target gene (D). Mycobacterial cells expressing both RecT annealase and Bxb1 integrase are coelectroporated with the targeting oligonucleotide and the payload plasmid. The ORBIT process is initiated at the replication fork. RecT annealase promotes annealing of the targeting oligonucleotide to the lagging strand template of the replication fork, integrating the attP site at a precise location in the chromosome. Subsequently, Bxb1 will promote site-specific recombination between this attP site and the attB site on the payload plasmid, resulting in the site-specific integration of the payload plasmid in the genome. For gene deletions (C) the oligonucleotide is designed so that the attP site replaces the target gene. For EGFP fusion (D) the oligonucleotide is designed so that the attP site is inserted before the stop codon, allowing in frame fusion of the EGFP tag to the target gene. In both cases, one can select for the successful recombinants by applying hygromycin selection. (E) Markerless gene deletions can be created by introducing the excision plasmid (pKM512) in the cells. This excision plasmid expresses the Bxb1 integrase and gp47 protein (a recombination directionality factor, RDF), that will promote site-specific recombination of the attL and attR sites, restoring the attP site and thereby deleting the selection markers. Figure adapted M. smegmatis has an editing efficiency as high as 70% and takes 9 days for one round of genome editing (instead of 16 days with HR [17, 47] ).
Further studies are required to investigate the applications of catalytically active Cas variants for genome editing in slow-growing mycobacteria. A low survival rate upon the formation of the DSB could limit the feasible implementation of the CRISPR-FnCpf1-assisted NHEJ system in slow-growing mycobacteria. Possibly, regulation of Cas9 expression could help improve the outcome of NHEJ-mediated DSB repair. However, a high amount of CRISPR escapers could impede the straightforward identification of positive clones [79] .
Random mutagenesis using transposons

Analyzing transposon mutant behavior in bulk
In the previous sections, we extensively discussed various site-directed gene replacement methods. Although the combination of specialized transduction and recombineering significantly improved AE efficiencies [49] , the phasmid cloning steps remain time-consuming, putting an impediment on the real high-throughput construction of genome-wide mycobacterial deletion mutants. The ORBIT method already circumvents this time-consuming step, but creating a genomewide mutant library in a gene-by-gene approach is still laborious. To this end, bulk mutant creation approaches are better suited, the most popular one being transposon mutagenesis. In its most common implementation, the Himar1 Mariner transposon (randomly inserting at TA dinucleotides) is transduced in the mycobacteria, allowing the generation of high-density transposon insertion libraries [31, 84] .
Using transposon mutagenesis, numerous genetic screens were conducted to elucidate genotype-phenotype relationships in different mycobacterial species. Phenotypic screens with individual mutants are limited by the assay's low throughput and the laborious steps to identify the site of insertion. Therefore, different semi-high throughput methods were designed (e.g. genomic footprinting [85] [86] [87] , signature-tagged mutagenesis [32, 88, 89] ) to assay large mutant pools. Sassetti et al. [90] were the first to develop a genome-wide approach using micro-array-based analysis, namely Transposon Site Hybridization or TRASH. However, it was the implementation of second-generation sequencing technologies that transformed the field. It allowed to monitor individual transposon mutants within a complex mixture by sequencing the transposon junctions that characterize each mutant, using a highthroughput, next-generation parallel sequencing approach [91] . After sequencing and data processing, the various conditions are probed for transposon disrupted genes that are depleted (or enriched), implicating their essential (or disadvantageous) roles in a particular condition. Since the initial publications [92] [93] [94] [95] , transposon sequencing (Tn-seq) is now the method of choice to unravel genotype-phenotype relationships in a wide range of bacteria [96] . In mycobacteria, Tn-seq has especially been used for probing the essentiality status of genes [97] [98] [99] [100] . Furthermore, it has been used for synthetic genetic array analyses [101] [102] [103] , assigning a function to several hypothetical mycobacterial genes by uncovering interactions with known genes or pathways.
From tracking individual transposon mutants to characterizing complete transposon libraries using CP-CSeq
Findings resulting from the analysis of transposon mutant behavior in bulk (e.g. via transposon sequencing) need to be validated and this often requires regeneration of individual mutants via conventional methods. Isolating individual mutants from an archived library was typically done by PCR on pooled subsets, scaling down until a single mutant was confirmed [4, 104] . Only few laboratories have put thorough effort in compiling larger sets of gene disruption mutants, available for the Mycobacterium research community. McAdam et al. [105] generated a resource of 1329 unique Tn5370 insertion mutants in the M. tb H37Rv strain, disrupting in total 351 ORFs. To obtain this, 2280 individual mutants were subjected to a genomic DNA preparation step, followed by a few rounds of PCR and sequencing to determine the transposon flanking genomic regions that determine the site of insertion. A similar approach was taken in the M. tb CDC1551 clinical isolate [106] , obtaining mutants in 878 genes with an initially comparable library size (1425 insertions). These early resources of M. tb mutants created a basis for further research into Mycobacterium biology [107] .
Characterization of mycobacterial transposon libraries through clone-by-clone sequencing of the transposon flanking regions is possible, but is obviously very laborious [105, 106] . Some methods were developed to characterize sequence-tagged biological entities such as mutants or cloned DNA [93, 108, 109] . All these approaches depend on the use of combinatorial pooling strategies in which pools are assigned barcodes. The identity of each specimen in the library is thus encoded within the pooling pattern. Deconvolution of this pattern allows to position the original specimen in the library. Using such combinatorial pooling, the number of pools can be kept much smaller than the number of specimens, allowing to drastically reduce the downstream workload. In general, these combinatorial methods are dependent on robotic equipment, that is not readily accessible for many scientists. Furthermore, the combinatorial pooling strategies are complex and require complex bioinformatics.
Our laboratory developed a method that is highly intuitive and uses the most common operational mode of liquid/clone handling robots, namely CP-CSeq or Cartesian-Pooling Coordinate Sequencing (Fig. 3 ) [110] . The method combines a 3D pooling strategy along the Cartesian coordinates with multiplex transposon sequencing to form a characterized ordered transposon library. These sample transfers (described in Fig. 3A ) are so intuitive that they can even be performed using manual or electronic 96 channel pipets, making the method accessible to any laboratory, including those without robots.
We demonstrated this approach in the M. bovis BCG Pasteur 1721 (streptomycin-resistant) strain, creating a transposon library of 96 9 96-well plates (containing 6383 traceable mutants) targeting up to 64% of the nonessential M. tb orthologues [110] . Transposon mutagenesis combined with CP-CSeq is thus an excellent tool to rapidly build libraries of genome-wide transposon insertion mutants in an isogenic background. CP-CSeq should enable any laboratory to characterize existing ordered transposon libraries, enhancing the utility of such mutant resources. Mutants of interest identified in Tn-seq experiments can then be easily extracted from the characterized library for validation of the Tn-seq findings or thorough investigation of the transposon mutant in question.
In fact, the method's concept is applicable to any entity for which sequence-tagged identification is possible, so any insertional mutant type; incl. specialized transduction mutants. We envision that the combination of enhanced specialized transduction in bulk (transducing a library of specialized transducing phages each targeting a single gene to ΔrecD mycobacterial strain expressing pJV53) and CP-CSeq can be used to rapidly generate an archived genome-wide mutant library in different mycobacterial strains. This would circumvent the need to separately transduce the strain of interest with the different phages. Performing ORBIT in bulk, by transforming array-synthesized oligonucleotide libraries and one payload plasmid, seems unachievable (at the moment) as it relies on electroporation to transform the targeting oligonucleotides and payload plasmid, which limits the overall efficiency of the method and circumvents its feasible upscaling.
In 2017, Barczak et al. [111] published on the systematic, multiparametric analysis of M. tb intracellular infection to identify novel functional relationships between genes that play a role in infection. They created a transposon library of~26 000 individual transposon mutants (~270 9 96-well plates), which they characterized by performing colony PCR (using a twostep process with one primer inside the transposon and one random primer for each PCR step) followed by Sanger sequencing to identify each transposon insertion site. The authors do not report on the implementation of combinatorial pooling to reduce the processing steps, neither do they mention the use of a robotic system to perform these vast amounts of colony PCRs and Sanger sequencing (26 000 in total). Nonetheless, this library is currently the largest resource of archived transposon mutants in any strain of the M. tb complex, probably targeting up to 90% of all nonessential M. tb genes [110] . Yet, neither complete list of all transposon insertions nor resource statistics was reported. From this parental transposon library of~26 000 transposon mutants, 2660 transposon mutants were selected to create an arrayed, nonredundant M. tb transposon mutant library which were screened in macrophages using high-content imaging, to systematically identify M. tb genes required for growth in infected host cells [111] .
Creating clean knockouts from transposon mutants
Although transposon insertion mutants are extremely valuable assets for fundamental mycobacterial research, they also have a few drawbacks. First of all, the mutants are generated by pseudo-random insertions, often leading to a loss-of-function, but to a sometimes unpredictable extent. This is inherently different from a classical KO mutant where part of the DNA sequence is removed in a predetermined way. Furthermore, the foreign DNA on the transposon increases the risk of polar effects, as these sequences can alter gene expression profiles of nearby up-and downstream genes. This necessitates extensive molecular and phenotypic characterization of each mutant before a certain function can be attributed to the gene in which the transposon insertion has occurred. In addition, the presence of the antibiotic selection marker hinders further engineering efforts (only one other effective antibiotic resistance marker being available, namely hygromycin) and it excludes the use of such mutants as vaccines (clean mutants are required for To create the first masterplate, the X-Y Pool Plate, a small culture volume of one specific well position (for example, A1) in all of the 96-well plates is transferred to and thus pooled in the same specific well (for example, A1) of the masterplate, thus keeping the respective positions within each primary plate (X and Y-coordinates). Subsequently, a second masterplate, the Z pool plate, is prepared by pooling all of the 96 wells of a primary plate in one single well of the masterplate (Z-coordinate) and doing this for each primary plate. As such all mutants of the first plate will be present in the first well and all mutants of the last plate in the last well of the Z pool plate. Next, each row and each column of both masterplates are pooled in column (n = 12) and row (n = 8) pools, giving a total of 40 samples that represent a library of 96 9 96 clones. Each mutant in the library is present in 4 of the 40 pools, as illustrated for a mutant in well E4 plate 96, keeping the positional information of each mutant. (B) Coordinate-Seq sequencing library preparation links a pool-specific barcode to the sequence tag that identifies each transposon mutant in each pool. (C) Coordinate-Sequencing data processing for transposon insertion mutants. clinical trials). Finally, reversion of a transposon mutant back to WT is theoretically possible in the exceedingly unlikely case that the bacterium would be transformed by DNA encoding for the entirely heterologous transposase. Nevertheless, transposon insertion mutants are highly valuable for fundamental mycobacterial research, but are currently difficult to develop for further clinical development (e.g. vaccine trials) as live-attenuated strains.
We developed a (semi-) high-throughput methodology to create genome-wide clean deletion mutants, by implementing molecular recombination and excision tools in the transposon mutagenesis toolbox (unpublished data). In this way, genome-wide transposon mutant resources can be rapidly generated with an option, to afterward, efficiently remove (most of) the foreign transposon DNA. For this, a derivative of the original Himar1 transposon was constructed (Fig. 4A,  B ). We implemented two systems to create unmarked mutants: FRT-sites for FlpE/FRT-mediated site-specific recombination and I-SceI sites for I-SceI meganuclease (ISceIM)-based transposon removal (Fig. 4C ). The first approach inherently leaves an FRT scar, whereas the last one has the potential of creating clean, markerless mutants. Different genetic carriers were investigated to bring in these unmarking proteins. For fast-growing mycobacteria like M. smegmatis, replicable vectors proved to be the best option, whereas temperature-sensitive phages (similar to PhAE280) or tetracyclin-inducible replicable vectors (optionally containing the GalK counterselectable marker for subsequent plasmid curing) were the best option for unmarking slow-growing mycobacteria (M. bovis BCG Danish) (unpublished data).
The I-SceI system provides a new way to remove marker genes from mycobacteria and can now be implemented in other mutagenesis methods (like twostep AE, dsDNA recombineering, specialized transduction and ORBIT). The system mostly results in small indels of different sizes, but in a small percent of cases bigger deletions are formed (percentages differ depending on the mycobacterial strain (unpublished data). So, screening is required to identify clones of interest having a small indel or a larger deletion. However, unlike site-specific recombination systems, no intact I-SceI sites remain in the genome (both I-SceI sites are destroyed), excluding the risk for unwanted genomic rearrangements due to remaining recognition sites.
By combining the use of CP-CSeq and the optimized transposon in the M. bovis BCG Danish 1331 (WHO reference, NIBSC 07/270) vaccine strain, we created a very large resource of BCG transposon mutants, from which clean KOs can be generated. The created resource in BCG Danish (two sets of 96 9 96-well plates containing 15 000 traceable transposon mutants) approaches genome saturation, as it targets 83% of all nonessential genes (excluding duplicated genes) (unpublished data). Unmarking of these transposon mutants only requires a straightforward introduction of ISceIM (via electroporation or transduction) and a colony PCR screen with custom primers on the genes of interest. As such, this research contributes to the global goal of creating genome-wide KO mutants in multiple strains of the M. tb complex.
For the creation of genome-wide mutant resources in different mycobacterial backgrounds, we envision the use of transposon mutagenesis in combination with CP-CSeq to target the bulk of the nonessential genes (~80%), with a cost of less than 3 € per characterized and library-localized mutant. The low cost of the method makes it worthwhile to repeat the method in different strains, if there is a good biomedical incentive for it. The remaining genes (~20%), that are hard to target via transposon mutagenesis (short genes and/or contain few TA's), could then be targeted by ORBIT [61] or specialized transduction [43, 49] .
Conclusion
Mycobacterial tools to make mutants have come a long way. The initial attempts to make mutants in these unruly bacteria were inefficient and cumbersome. With the refinement of specialized transduction [43, 49] , the development of ORBIT [61] and the new tools for transposon mutagenesis (including CP-CSeq [110] and the optimized transposon (unpublished data)), the creation of mutants in slow-growing mycobacteria has become feasible. The characteristics of the available methods are summarized in Table 2 . Furthermore, several research groups have done (or are doing) the effort to create large mutant resources and make them publicly available to the scientific community in order to nurture mycobacterial research all over the world [43, 49, 51, [105] [106] [107] 115] . Such resources are soon to be truly genomewide, which will be a milestone for research on humanity's most deadly pathogen. Finally, the implementation of CRISPR-Cas gene editing in M. smegmatis provides hope that we can implement CRISPR-Cas gene editing in slow-growing mycobacteria in a feasible manner, although this still needs to be tested. Moreover, the long duration until this is reported suggests that unforeseen problems are encountered.
The powerful repertoire of mycobacterial genetic tools that is now available will speed up the elucidation of mycobacterial pathogenesis and drug resistance pathways. Moreover, it facilitates the development of 
